| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 08/09/2006 | EP1687278A1 Use of 4-cyano-naphthalene-1, 8-dicarboximide derivatives and related compounds to protect organic material from the damaging effects of light |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | CN1816543A Indole derivatives with apoptosis-inducing effect |
| 08/09/2006 | CN1816528A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1816527A Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin |
| 08/09/2006 | CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1816341A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1268623C Novel composition and method or stabilizing same |
| 08/08/2006 | US7087749 Substituted piperidine compounds and methods of their use |
| 08/03/2006 | US20060173027 Spirocvclic piperidines as mch1 antagonists and uses thereof |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/02/2006 | EP1685131A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/01/2006 | US7084274 heating 3-oxo-4-aza-5-androstene in a mixture of formic acid and an alkanediol in the presence of zinc. |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 07/27/2006 | US20060167257 Acridinone based multiple ring fluorescent dyes, linkable forms of fluorescent dyes, energy transfer dyes, reagents labeled with fluorescent dyes |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060166944 tetracycline derivatives such as 4-Oximinominocycline, used for the treatment of bacterial infections, as antitumor agents, blocking tetracycline efflux and modulation of gene expression |
| 07/27/2006 | US20060166034 Monoaminofluorene compound and organic light-emitting device using the same |
| 07/26/2006 | EP1682510A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | EP1601672B1 Triazolo-pyridines as anti-inflammatory compounds |
| 07/26/2006 | CN1809563A Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 07/26/2006 | CN1809349A 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine A2A receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation |
| 07/26/2006 | CN1266153C Treatment for mother liquid obtained in preparation of high-purity triethylenediamine |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081455 sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 07/20/2006 | WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/19/2006 | EP1451133A4 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 07/19/2006 | EP0996447B1 Combination therapy for modulating the human sexual response |
| 07/19/2006 | CN1805959A Cycloalkanepyrrolopyridines as DP receptor antagonists |
| 07/19/2006 | CN1803802A Method for synthesizing oxazole pyridone compound |
| 07/19/2006 | CN1264841C Preparation of anti-cancer active material in camptothecinum cell and method for restraining cancer cell |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264822C Process for preparing high-purity huperzine A |
| 07/18/2006 | USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics |
| 07/18/2006 | US7078115 Metal coordination compound and electroluminescence device |
| 07/13/2006 | WO2005112945A3 Synthesis of tetracyclines and analogues thereof |
| 07/13/2006 | US20060154949 Arylindenopyridines and related therapeutic and prophylactic methods |
| 07/13/2006 | US20060154947 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 07/12/2006 | EP1678172A2 Azabicyclic compounds for relieving pain and treating central nervous system disorders |
| 07/12/2006 | EP1394156B1 Chromene compound |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | CN1802373A Pyrazoloisoquinoline derivatives as kinase inhibitors |
| 07/12/2006 | CN1264153C 光记录介质 The optical recording medium |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/12/2006 | CN1263744C Substituted transannular tetracarboxylic acid diimide |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/06/2006 | WO2006072039A1 Nepetalactams and n-substituted derivatives thereof |
| 07/06/2006 | WO2006072037A1 Dihydronepetalactams and n-substituted derivatives thereof |
| 07/06/2006 | WO2006069775A1 5-ht7 receptor antagonists |
| 07/06/2006 | WO2005048315A3 Light emitting devices and materials for use in the devices |
| 07/06/2006 | US20060149068 Liquid phase process for the synthesis of annulated pyridines over molecular sieve catalysts |
| 07/06/2006 | US20060148842 Nepetalactams and N-substituted derivatives thereof |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/06/2006 | US20060148724 Genipin derivatives and uses thereof |
| 07/06/2006 | US20060144289 Acid red 82 in mixtures |
| 07/06/2006 | CA2592070A1 Nepetalactams and n-substituted derivatives thereof |
| 07/06/2006 | CA2592066A1 Dihydronepetalactams and n-substituted derivatives thereof |
| 07/06/2006 | CA2591201A1 5-ht7 receptor antagonists |
| 07/05/2006 | EP1676840A1 5-HT7 Receptor antagonists |
| 07/05/2006 | EP1313739B1 Alkylated imidazopyridine derivatives |
| 07/05/2006 | CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren |
| 07/05/2006 | CN1796390A 9a,11 ¿C dinitrogen ¿C acene [b] fluorenone,preparation method and application in preparing medication |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071186 Drug abuse; antiserotonine agents; central nervous system disorders; sleep disorders |
| 06/28/2006 | EP1673354A1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | EP1554276B1 Non-nucleoside reverse transcriptase inhibitors |
| 06/28/2006 | EP0924213B1 Pyridobenzoxazine derivatives |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/27/2006 | US7067668 Controlling fungi in plants |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | US20060135774 Method for producing pigment transparent preparations based on perylene-3,4,9,10-tetracarboxylic acid diimine |
| 06/22/2006 | US20060135547 Combining a solution of desloratadine in an organic solvent selected from the group consisting of a C2 to C5 alkyl acetate, butanol, isobutanol, toluene and chloroform with a C5 to C12 hydrocarbon to precipitate the mixture, recovering the mixture |
| 06/22/2006 | CA2589363A1 Spiro derivatives as lipoxygenase inhibitors |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1670459A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP0815100B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/21/2006 | CN1791401A Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
| 06/21/2006 | CN1789267A Method for synthesizing tricyclic compound |
| 06/21/2006 | CN1260230C Production process of camptothecin |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 06/15/2006 | US20060128737 Androgen receptor agonists |